A detailed history of Bridgefront Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bridgefront Capital, LLC holds 3,679 shares of BDX stock, worth $840,614. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,679
Previous 4,179 11.96%
Holding current value
$840,614
Previous $976,000 9.12%
% of portfolio
0.36%
Previous 0.41%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $110,735 - $121,205
-500 Reduced 11.96%
3,679 $887,000
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $940,567 - $1.03 Million
4,179 New
4,179 $976,000
Q3 2022

Nov 29, 2022

BUY
$51.03 - $264.23 $84,709 - $438,621
1,660 New
1,660 $370,000
Q2 2021

Aug 12, 2021

SELL
$232.65 - $254.58 $489,960 - $536,145
-2,106 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $488,781 - $540,989
2,106 New
2,106 $512,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.